These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36243253)

  • 1. Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider?
    Bay M C; Núñez F P; Quera R; Yarur AJ
    Gastroenterol Hepatol; 2023 Feb; 46(2):139-147. PubMed ID: 36243253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhoidectomy and Excision of Skin Tags in IBD: Harbinger of Doom or Simply a Disease Running Its Course?
    McKenna NP; Lightner AL; Habermann EB; Mathis KL
    Dis Colon Rectum; 2019 Dec; 62(12):1505-1511. PubMed ID: 31580261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Blood Eosinophilia and Long-term Severity in Pediatric-Onset Inflammatory Bowel Disease.
    Prathapan KM; Ramos Rivers C; Anderson A; Koutroumpakis F; Koutroubakis IE; Babichenko D; Tan X; Tang G; Schwartz M; Proksell S; Johnston E; Hashash JG; Dunn M; Wilson A; Barrie A; Harrison J; Hartman D; Kim SC; Binion DG
    Inflamm Bowel Dis; 2020 Nov; 26(12):1890-1900. PubMed ID: 31960916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part).
    Yamamoto-Furusho JK; Bosques-Padilla F; Daffra P; De Paula JA; Etchevers J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Marroquín de la Garza JM; Monreal Robles R; Rocha JL; Steinwurz F; Vázquez-Frías R; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(2):134-155. PubMed ID: 28318706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional Care for Patients with Inflammatory Bowel Disease: Japanese Experience.
    Kumagai H; Suzuki Y; Shimizu T
    Digestion; 2021; 102(1):18-24. PubMed ID: 33032280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease.
    Parrish AB; Lopez NE; Truong A; Zaghiyan K; Melmed GY; McGovern DPB; Ha C; Syal G; Bonthala N; Jain A; Landers CJ; Targan SR; Fleshner P
    Dis Colon Rectum; 2021 Oct; 64(10):1259-1266. PubMed ID: 34516445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions on the surgical treatment of inflammatory bowel disease in Spain. Results of a national survey.
    Sánchez-Guillén L; Blanco-Antona F; Millán-Scheiding M
    Cir Esp; 2016 Dec; 94(10):560-568. PubMed ID: 27887705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ESPEN guideline: Clinical nutrition in inflammatory bowel disease].
    Bischoff SC; Escher J; Hébuterne X; Kłęk S; Krznaric Z; Schneider S; Shamir R; Stardelova K; Wierdsma N; Wiskin AE; Forbes A; Montoro M; Burgos Peláez R
    Nutr Hosp; 2022 Jun; 39(3):678-703. PubMed ID: 35014851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU.
    Yamamoto-Furusho JK; Andrade D; Barahona J; Bautista S; Bosques-Padilla F; de Paula J; Galiano MT; Iade B; Juliao-Baños F; Otoya G; Steinwurz F; Torres E; Veitia G; Barreiro-de Acosta M
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(1):89-102. PubMed ID: 34866040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key?
    Kim J; Ye BD
    Pediatr Gastroenterol Hepatol Nutr; 2019 Jan; 22(1):28-40. PubMed ID: 30671371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?
    Kim J; Ye BD
    Intest Res; 2019 Jan; 17(1):24-35. PubMed ID: 30419636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations of the Spanish Working Group on Crohn's disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU) on dysplasia screening in inflammatory bowel disease patients.
    Sicilia B; Vicente R; Arias L; Echarri A; Zabana Y; Mañosa M; Beltrán B; Barreiro-de Acosta M;
    Gastroenterol Hepatol; 2021; 44(6):435-447. PubMed ID: 33592179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
    Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
    Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.
    Barreiro-de Acosta M; Marín-Jiménez I; Panadero A; Guardiola J; Cañas M; Gobbo Montoya M; Modino Y; Alcaín G; Bosca-Watts MM; Calvet X; Casellas F; Chaparro M; Fernández Salazar L; Ferreiro-Iglesias R; Ginard D; Iborra M; Manceñido N; Mañosa M; Merino O; Rivero M; Roncero O; Sempere L; Vega P; Zabana Y; Mínguez M; Nos P; Gisbert JP
    Gastroenterol Hepatol; 2018 Feb; 41(2):118-127. PubMed ID: 29275001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned Transition of Adolescent Patients with Inflammatory Bowel Disease Results in Higher Remission Rates.
    Otto C; Tárnok A; Erős A; Szakács Z; Vincze Á; Farkas N; Sarlós P
    J Pediatr Nurs; 2019; 45():62-66. PubMed ID: 30745207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Inflammatory Bowel Disease.
    Bouhuys M; Lexmond WS; van Rheenen PF
    Pediatrics; 2023 Jan; 151(1):. PubMed ID: 36545774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
    Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.